HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al.

Abstract
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Segebladh B, Borgström A, Nyberg S, et al. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 2009;201:139.e1-8.
AuthorsEmily S Jungheim, Jessica J Kenerson, Nastaran Foyouzi-Yousefi, Jenifer E Allsworth, Kerri L Marquard
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 201 Issue 2 Pg. e1-5 (Aug 2009) ISSN: 1097-6868 [Electronic] United States
PMID19646561 (Publication Type: Comment, Journal Article)
Chemical References
  • Estrogens
  • Gonadotropin-Releasing Hormone
  • Progesterone
Topics
  • Drug Therapy, Combination
  • Estrogens (therapeutic use)
  • Female
  • Gonadotropin-Releasing Hormone (agonists)
  • Humans
  • Premenstrual Syndrome (drug therapy)
  • Progesterone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: